Green Biologics Ltd., established in 2003, is headquartered in the United Kingdom and operates within the Biotechnology industry. The company stands out for its innovative merger of microbiology and chemistry to produce sustainable ingredients that enhance consumer goods and industrial products. Their product offerings include bio acetone, n-butanol, and IPA, renewable alternatives that eschew traditional petrochemical commodities.
Beyond being eco-friendly, these products offer superior performance without compromising quality or profit margins, catering to fields ranging from specialty coatings to personal care and plastics. In alignment with the global push towards sustainability, Green Biologics supports corporate sustainability initiatives by delivering transparent and high-performing natural product lines.
The company last secured a $34 million Debt Financing investment on January 21, 2015, with backing from Tennenbaum Capital Partners. This highlights investor confidence in their mission and potential for market disruption.